New York City Federal Pharmacy and DME Fraud Lawyer

Federal prosecutors treat pharmacy fraud and durable medical equipment billing schemes as serious organized crime, not paperwork errors. The Department of Justice, working alongside the Department of Health and Human Services Office of Inspector General and the FBI’s healthcare fraud units, dedicates substantial investigative resources to these cases before a single arrest is made. By the time you receive a target letter or a federal grand jury subpoena, agents have frequently spent months or years building their file, reviewing billing records, interviewing employees, and tracing financial flows through multiple entities. Retaining a New York City federal pharmacy and DME fraud lawyer at the earliest possible moment is not a precaution; it is the decision that shapes everything that follows.

These investigations unfold in stages that are rarely visible to the target until investigators are ready to move. A routine audit from a Medicare Administrative Contractor can quietly escalate into a Zone Program Integrity Contractor review, then into a referral to federal law enforcement, all without the provider receiving any formal notice. When the knock comes, or the grand jury subpoena arrives, the investigation is already mature. The government has already built a theory. Your attorney’s job, from that moment forward, is to understand exactly what that theory is, identify where it is weakest, and either dismantle it before charges are filed or position the defense for the best possible outcome at trial or in negotiations.

Federal pharmacy and DME fraud cases in New York are prosecuted out of both the Southern District and the Eastern District of New York, two of the most active and sophisticated federal prosecutors’ offices in the country. The U.S. Attorney’s offices in Manhattan and Brooklyn have both secured substantial convictions in healthcare fraud cases involving kickback arrangements, false billing schemes, and compounding pharmacy fraud. Whoever ends up prosecuting the case will be experienced and well-resourced. That reality makes defense preparation, and the attorney you choose, consequential.

Charges That Arise in Federal Pharmacy and DME Fraud Cases

• Healthcare Fraud under 18 U.S.C. 1347: The core federal statute prohibiting knowingly executing a scheme to defraud any healthcare benefit program, covering false billing to Medicare, Medicaid, TRICARE, and private insurers; prosecutors frequently charge this alongside wire fraud to expand the government’s charging toolkit.
• Anti-Kickback Statute Violations: Federal law prohibits offering, paying, soliciting, or receiving anything of value to induce or reward referrals for services covered by federal healthcare programs; pharmacy and DME cases routinely involve allegations of payments to prescribers, patient recruiters, or telemedicine companies in exchange for referrals or prescriptions.
• False Claims Act Exposure: Pharmacies and DME suppliers that submit false or fraudulent claims to Medicare or Medicaid face civil liability under the False Claims Act, including treble damages and per-claim penalties; False Claims Act cases are sometimes brought by qui tam relators, meaning a whistleblower, frequently a current or former employee, may have already triggered the investigation.
• Controlled Substance Diversion: Pharmacies dispensing opioids or other controlled substances based on invalid prescriptions, or outside the usual course of professional practice, face prosecution under the Controlled Substances Act in addition to healthcare fraud statutes; these charges carry significant mandatory minimum exposure.
• Money Laundering: When fraud proceeds are moved through business accounts, distributed among owners, or used to purchase assets, prosecutors add money laundering counts, which can dramatically increase sentencing exposure and trigger forfeiture of property, bank accounts, and equipment.
• Compounding Pharmacy Fraud: Federal prosecutors have aggressively targeted compounding pharmacies that billed high-cost compounded medications to TRICARE or commercial insurers based on prescriptions generated through telehealth mills or patient brokering arrangements; many of these prosecutions originate from national schemes with New York connections.
• Identity-Related Billing Offenses: Using a beneficiary’s identity without their knowledge, billing for deceased patients, or using provider numbers without authorization generates identity theft and aggravated identity theft charges layered on top of the core fraud counts.

What the Federal Investigation Process Actually Looks Like for Providers and Owners

Most pharmacy and DME fraud investigations begin not with an arrest but with data. The Centers for Medicare and Medicaid Services uses sophisticated analytics to flag billing patterns that deviate from peer norms, whether that is an unusual volume of a specific drug class, high rates of a particular HCPCS billing code, or a concentration of claims from a narrow geographic cluster of beneficiaries. A flag at CMS does not mean prosecution is coming, but it may trigger a request for records that providers sometimes handle poorly, without counsel, believing cooperation will resolve the matter. It frequently does not.

Once federal law enforcement agencies are involved, the investigation can run in parallel with civil audit activity. A provider may be responding to a Medicare audit while federal agents are simultaneously interviewing former employees, reviewing patient files obtained through subpoena, and building a case map that ties the provider’s billing to specific prescribers or beneficiaries. By the time a search warrant is executed at the pharmacy or the DME supplier, agents typically have a detailed picture of the alleged scheme. The search itself is designed to fill specific evidentiary gaps and to locate records that corroborate cooperating witness testimony.

If you are a pharmacy owner, a pharmacist, a DME supplier, a billing manager, or anyone whose name appears in the business records of an entity under investigation, you should assume that your communications, financial records, and employee statements are already part of the government’s file. The first priority is understanding what the government has and what they believe the evidence shows. A federal pharmacy and DME fraud attorney in New York can engage at this stage to assess exposure, determine whether a proffer or cooperation agreement serves your interests, challenge investigative overreach, or begin preparing a pre-indictment presentation to the prosecutors’ office arguing against charges.

If charges are filed in the Southern or Eastern District, the case will be assigned to a federal district court judge in Manhattan or Brooklyn, respectively. Arraignment typically follows within days of an indictment. At that point, the discovery process begins under federal rules, and the defense begins receiving the materials the government has compiled. Federal healthcare fraud cases often involve millions of pages of billing records, financial data, and medical files. Organizing and analyzing that discovery is labor-intensive work that requires both legal strategy and forensic review, often with the assistance of billing experts and healthcare consultants who can explain to a jury why certain billing decisions were clinically and administratively reasonable.

Why Jason Goldman’s Background Matters for Federal Healthcare Fraud Defense

Federal pharmacy and DME fraud cases require an attorney who is comfortable in federal court, understands how prosecutors build complex financial crime cases, and knows how to take a case to verdict when necessary. Jason Goldman began his career as a Brooklyn prosecutor, giving him direct insight into how the government approaches multi-defendant, document-heavy investigations. That experience translates directly into understanding what federal prosecutors in the Southern and Eastern Districts are likely to prioritize, where their theories of liability are most vulnerable, and how to communicate a defense narrative that resonates with a federal jury.

Mr. Goldman has tried over 25 cases to verdict and has built a practice that spans pre-arrest investigations through trials and appeals. His work with private investigators and forensic experts is central to how he approaches cases with complex documentary records, exactly the kind of case that healthcare fraud prosecutions become. He has been recognized by outlets including the New York Post, Fox 5, and WABC for his work on high-profile, high-stakes matters, and he has been described by the Chelsea News as having “a history of getting high-profile defendants off.” For a pharmacy owner or DME supplier facing federal charges that could result in exclusion from federal healthcare programs, significant prison time, and financial penalties, that track record is directly relevant.

The firm also brings a strategic layer that goes beyond courtroom advocacy. Mr. Goldman operates as a trusted advisor to clients whose professional reputations are at risk alongside their liberty. For licensed pharmacists, physicians who own DME companies, or healthcare executives whose careers are tied to their ability to participate in federal programs, controlling how an investigation is perceived, both publicly and within the professional community, can be as important as the legal outcome. Mr. Goldman’s network of public relations and crisis communications professionals, combined with his strategic media experience, means clients have support on every front where the case plays out.

Questions People Ask About Federal Pharmacy and DME Fraud Cases

What is the difference between a civil audit and a criminal investigation?

A civil audit from CMS or a Medicare Administrative Contractor is an administrative process seeking repayment for improperly billed claims. A criminal investigation involves law enforcement agents and prosecutors building a case for prosecution. The two processes can run simultaneously, and statements made or records produced in a civil context can be used in a criminal proceeding. If there is any indication that federal law enforcement is involved, treating the matter as purely administrative is a serious mistake.

Can I be prosecuted if I did not personally submit the false claims?

Yes. Federal prosecutors frequently charge pharmacy and DME company owners under aiding and abetting theories or under the concept of responsible corporate officer liability, arguing that someone in a leadership position had the authority and responsibility to prevent billing fraud and failed to do so. You do not have to have personally typed a claim number into a billing system to face federal charges.

What does it mean to receive a grand jury subpoena for records?

A grand jury subpoena for documents means that a federal grand jury, typically impaneled at the direction of federal prosecutors, is investigating conduct that may involve your business or you personally. You are legally required to comply unless you assert a valid privilege. Before producing a single document, you should consult with a federal pharmacy and DME fraud attorney. How you respond, what you produce, what you withhold, and how you organize the production can all affect your exposure.

How does the Anti-Kickback Statute apply to legitimate business relationships?

The Anti-Kickback Statute is broad, and what looks like a normal referral relationship or marketing arrangement can technically implicate it if any part of the compensation relates to referrals for federally covered services. There are statutory safe harbors, such as for employment relationships, personal services agreements, and certain discounts, but they have specific requirements. Many defendants in these cases had business relationships they believed were structured correctly. Whether the safe harbor actually applies is a factual and legal question the defense can contest.

Will I lose my pharmacy license or be excluded from Medicare if I am charged?

A conviction for healthcare fraud triggers mandatory exclusion from Medicare, Medicaid, and other federal healthcare programs under the OIG’s exclusion authority. This is separate from any state licensing action, which the New York State Department of Education’s Office of the Professions can pursue independently. These collateral consequences can effectively end a career even if a criminal sentence is minimal. Defense strategy must account for these consequences from the beginning, not as an afterthought after sentencing.

What is a qui tam lawsuit, and could one already be pending against my pharmacy or DME company?

A qui tam suit under the False Claims Act allows a private individual, called a relator, to file a lawsuit on the government’s behalf alleging fraud against federal programs. These suits are filed under seal, meaning you may not know one exists. The government investigates while the case remains sealed and then decides whether to intervene and take over the litigation. Many healthcare fraud criminal investigations originate from sealed qui tam filings. If you suspect a former employee filed one, your attorney can sometimes gather information through strategic channels, though the seal limits direct inquiry.

Can I negotiate a civil settlement with the government to avoid criminal prosecution?

Sometimes, but it requires careful strategy. The Department of Justice’s civil and criminal divisions operate separately, and a civil resolution does not automatically preclude criminal prosecution. Prosecutors may agree to resolve a matter civilly if the evidence of criminal intent is thin or if cooperation is offered. These negotiations require experienced federal criminal defense counsel because statements made during civil settlement discussions can carry risk if the criminal side of the investigation is still active.

What happens to my pharmacy or DME company during a federal investigation?

If a search warrant is executed, federal agents will arrive with specific lists of items to seize, typically computers, billing records, patient files, and financial documents. Business operations may be disrupted, and employees may be interviewed on-site. The seizure of electronic records can effectively halt operations. Your attorney can work to narrow the scope of a warrant after the fact and to ensure that seized records used in ongoing patient care are returned or made accessible. There may also be mechanisms to seek the return of property not covered by the warrant.

Is it worth fighting federal pharmacy fraud charges if the government has billing records?

Billing records establish what was submitted; they do not establish intent, which is a required element of most federal fraud statutes. The government must prove that false claims were submitted knowingly and willfully. Billing errors, software malfunctions, reliance on coding advice, or misunderstanding of complex Medicare billing rules can all be relevant to intent. Many cases that look overwhelming on the billing record level become genuinely contestable when the full factual picture is developed through discovery and expert analysis.

What is the sentencing exposure for a federal pharmacy or DME fraud conviction?

Federal sentencing in healthcare fraud cases is driven primarily by the loss amount, which is calculated under the federal sentencing guidelines. Higher loss amounts drive higher guideline ranges. Additional enhancements apply for sophisticated means, for a leadership role in the scheme, and for the number of victims. However, the guidelines are advisory under current federal law, and judges have discretion to impose sentences below the calculated range based on variance arguments. Effective sentencing advocacy, which is a distinct phase of representation, can make a significant difference in outcome even after conviction.

Federal Pharmacy and DME Fraud Representation Across New York City and Beyond

The Law Offices of Jason Goldman represents pharmacy owners, pharmacists, DME company owners and operators, billing personnel, and healthcare executives across all five boroughs and the surrounding region. This includes clients in Manhattan neighborhoods from Midtown and Tribeca through Washington Heights and East Harlem, clients in Brooklyn communities including Crown Heights, Flatbush, Bay Ridge, Borough Park, and Brownsville, and clients throughout Queens in areas like Flushing, Jamaica, Astoria, Richmond Hill, and Jackson Heights. The firm also serves clients in the Bronx, across Staten Island, and in suburban counties including Westchester, Nassau, and Suffolk, where pharmacy and DME businesses frequently operate and where federal investigations have become increasingly active.

Cases originating in the Southern District of New York, seated in Manhattan, and in the Eastern District of New York, seated in Brooklyn with additional courtrooms in Central Islip, are both within the firm’s regular practice. Mr. Goldman is also admitted to practice pro hac vice throughout the country, meaning that clients whose cases involve multi-district investigations or charges filed in federal courts outside New York can be represented without requiring separate local counsel to take the lead.

Speak with a New York City Federal Healthcare Fraud Attorney

Federal pharmacy and DME fraud charges can unravel everything a provider has built, professionally, financially, and personally. Whether you have received a subpoena, become aware that your billing is under scrutiny, or have already been charged in federal court, the conversation you have with a New York City federal healthcare fraud attorney in the earliest stages of the case will define your options going forward. The Law Offices of Jason Goldman offers elite, selective representation built on meticulous preparation, prosecutorial experience, and a clear-eyed understanding of what it takes to win in federal court. Contact the firm today to schedule a consultation.